Patients’ and Clinicians’ Experiences Using a Real-Time Remote Monitoring System for Chemotherapy Symptom Management
Author Information
Author(s): Mavragani Amaryllis, Crafoord Marie-Therése, Fridriksdottir Nanna, Stover Angela, McCann Lisa, Lewis Liane, Oduntan Olubukola, Harris Jenny, Darley Andrew, Berg Geir V, Lubowitzki Simone, Cheevers Katy, Miller Morven, Armes Jo, Ream Emma, Fox Patricia, Furlong Eileen Patricia, Gaiger Alexander, Kotronoulas Grigorios, Patiraki Elisabeth, Katsaragakis Stylianos, McCrone Paul, Miaskowski Christine, Cardone Antonella, Orr Dawn, Flowerday Adrian, Skene Simon, Moore Margaret, De Souza Nicosha, Donnan Peter, Maguire Roma
Primary Institution: University of Strathclyde
Hypothesis
How do patients and clinicians experience the Advanced Symptom Management System (ASyMS) during chemotherapy?
Conclusion
The study found that both patients and clinicians had positive experiences using ASyMS, which helped improve symptom management during chemotherapy.
Supporting Evidence
- Patients reported feeling safer at home due to the real-time monitoring provided by ASyMS.
- Clinicians noted that ASyMS improved their ability to respond quickly to patients' symptoms.
- Both patients and clinicians found that ASyMS enhanced communication and relationships.
- Patients expressed that ASyMS helped them understand what symptoms were normal during treatment.
- Some patients experienced fatigue from daily symptom reporting as treatment progressed.
Takeaway
This study shows that a special app can help cancer patients and their doctors keep track of symptoms during treatment, making everyone feel safer and more supported.
Methodology
The study used semistructured interviews with 29 patients and 18 clinicians across 5 European countries to gather qualitative data on their experiences with ASyMS.
Potential Biases
The study did not include control group patients, which may lead to a positivity bias in the reported experiences.
Limitations
The study primarily included younger female patients with breast cancer, which may limit the generalizability of the findings.
Participant Demographics
{"patients":{"mean_age":48.1,"gender_distribution":{"female":22,"male":7},"cancer_types":{"breast":19,"colorectal":3,"hematological":7}},"clinicians":{"mean_age":39.8,"gender_distribution":{"female":13,"male":5}}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website